Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two ...

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On ...

TLOG TetraLogic Pharmaceuticals Corporation Peers & Competitors Follow 1.72K followers $0.0002 0.00 (0.00) 11:08 AM 03/30/26 ...

TetraLogic Pharmaceuticals Corp. Annual stock financials by MarketWatch. View the latest TLOG financial statements, income statements and financial ratios.

Find the latest TetraLogic Pharmaceuticals Corporation (TLOG) stock quote, history, news and other vital information to help you with your stock trading and investing.

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...

Find the latest TetraLogic Pharmaceuticals Corporation (TLOG) stock quote, history, news and other vital information to help you with your stock trading and investing.

TetraLogic Pharmaceuticals Corp. Annual cash flow by MarketWatch. View TLOG net cash flow, operating cash flow, operating expenses and cash dividends.

At close: 17 April at 4:00:00 pm GMT-4 ...

Review the current valuation for TetraLogic Pharmaceuticals Corp (TLOG:OTCM) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

Research reports are not currently available for TLOG.